These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3531027)

  • 21. Interactions between antibacterial agents of the quinolone group and nitrofurantoin.
    Shah S; Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21(1):41-8. PubMed ID: 3356622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of newer quinolones against Legionella group organisms.
    Greenwood D; Laverick A
    Lancet; 1983 Jul; 2(8344):279-80. PubMed ID: 6135099
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial activity of some novel arylthiobenzo[f]quinolines.
    Bahuguna RP; Joshi BC; Mangal HN
    Pharmazie; 1986 Sep; 41(9):672. PubMed ID: 3797464
    [No Abstract]   [Full Text] [Related]  

  • 24. The quinolones.
    Lancet; 1984 Jan; 1(8367):24-5. PubMed ID: 6140347
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial sensitivity of Neisseria gonorrhoeae to spectinomycin & rosoxacin.
    Bhujwala RA; Bhargava NC; Biswas TD; Narain S; Pandhi RK
    Indian J Med Res; 1987 Dec; 86():702-6. PubMed ID: 2967246
    [No Abstract]   [Full Text] [Related]  

  • 26. Quinolones--a paradoxical adolescence.
    Lancet; 1986 Apr; 1(8485):837-9. PubMed ID: 2870319
    [No Abstract]   [Full Text] [Related]  

  • 27. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    Wise R; Andrews JM; Danks G
    J Antimicrob Chemother; 1984 Mar; 13(3):237-44. PubMed ID: 6586712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.
    Cometta A; Marchetti O; Calandra T; Bille J; Kern WV; Zinner S;
    Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):537-40. PubMed ID: 16896825
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone.
    Tanaka K; Mikamo H; Nakao K; Watanabe K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3908-13. PubMed ID: 17065629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of rosoxacin against Haemophilus influenzae.
    Jurek EA; Weiner LB; Granato PA
    Chemotherapy; 1983; 29(4):262-4. PubMed ID: 6603337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of "oxyn" group compounds as antimicrobial substances against phytopathogenic bacteria].
    Bel'tiukova KI; Koroleva IB; Rotmistrov MM; Kulik GV
    Mikrobiol Zh; 1973; 35(5):635-8. PubMed ID: 4783478
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative activity of the 4-quinolones.
    Phillips I; King A
    Rev Infect Dis; 1988; 10 Suppl 1():S70-6. PubMed ID: 3279501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
    Hirschhorn L; Neu HC
    Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    Berlin OG; Young LS; Bruckner DA
    J Antimicrob Chemother; 1987 May; 19(5):611-5. PubMed ID: 3112095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Broad-spectrum quinolones (2d-generation quinolones)].
    Neuman M
    Therapie; 1986; 41(2):123-8. PubMed ID: 3726784
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
    Chin NX; Figueredo VM; Novelli A; Neu HC
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New quinolones].
    Matsumoto F; Morita M; Sato Y
    Nihon Rinsho; 1990 Oct; 48(10):2205-11. PubMed ID: 2177796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.